EUVIMEDEUVIMED entdecken
Crossref

Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout

Aleš Kvasnička, David Friedecký, Barbora Piskláková, Jakub Rozhon, Karel Pavelka, Blanka Stibůrková

Vascular Pharmacology · 2025

DOI: 10.1016/j.vph.2025.107495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von Aleš Kvasnička und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc and Faculty of Medicine and Dentistry,…. Hauptthemen laut MEDLINE: Hyperuricemia, Gout, Ceramides, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gout and hyperuricemia increase cardiovascular disease risk, highlighting the need for improved risk stratification. In this pilot study, we evaluated the Coronary Event Risk Test (CERT) in 94 hyperuricemic and 196 gout patients, and 53 controls. Plasma ceramides were determined by liquid chromatography-mass spectrometry. Elevated CERT scores (≥7) occurred in 11.7 % (2-fold increase) of hyperuricemic and 31.12 % (5.5-fold increase) of gout patients compared to controls. Additionally, both hyperuricemic and gout patients with increased CERT also exhibited higher levels of inflammation and atherogenic index of plasma, both of which were significantly associated with CERT. Incorporating CERT into routine care may enhance risk stratification and guide targeted interventions in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaGoutCeramidesCardiovascular DiseasesDecision Support TechniquesUric AcidHumansMaleMiddle AgedRisk AssessmentFemalePilot ProjectsBiomarkersAgedPredictive Value of TestsHeart Disease Risk FactorsCase-Control StudiesChromatography, LiquidPrognosisAdult

Stichwörter der Autor:innen

Cardiovascular riskCeramidesCoronary event risk testGoutHyperuricemiaLipidomics

Substanzen

CeramidesBiomarkersUric Acid

Autor:innen und Institutionen

  • Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic.
  • Institute of Rheumatology, Prague, Czech Republic.
  • Institute of Rheumatology, Prague, Czech Republic; Department of Pediatrics and Inherited Metabolic Disorders, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Repub…

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Kvasnička, A., Friedecký, D., Piskláková, B., Rozhon, J., Pavelka, K., & Stibůrková, B. (2025). Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2025.107495

Vancouver

Kvasnička A, Friedecký D, Piskláková B, Rozhon J, Pavelka K, Stibůrková B. Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2025.107495

BibTeX
@article{Kvasnika2025,
  author = {Kvasnička, Aleš and Friedecký, David and Piskláková, Barbora and Rozhon, Jakub and Pavelka, Karel and Stibůrková, Blanka},
  title = {Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout},
  journal = {Vascular Pharmacology},
  year = {2025},
  doi = {10.1016/j.vph.2025.107495}
}
Kostenlos starten →